4//SEC Filing
RYAN ARTHUR F 4
Accession 0001968202-24-000130
CIK 0000872589other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:02 PM ET
Size
34.1 KB
Accession
0001968202-24-000130
Insider Transaction Report
Form 4
RYAN ARTHUR F
Director
Transactions
- Sale
Common Stock
2024-10-01$1053.45/sh−4$4,214→ 17,592 total - Sale
Common Stock
2024-10-01$1041.35/sh−3$3,124→ 17,679 total - Sale
Common Stock
2024-10-01$1043.39/sh−5$5,217→ 17,673 total - Sale
Common Stock
2024-10-01$1045.27/sh−7$7,317→ 17,657 total - Sale
Common Stock
2024-10-01$1047.44/sh−12$12,569→ 17,636 total - Sale
Common Stock
2024-10-01$1048.54/sh−12$12,582→ 17,624 total - Sale
Common Stock
2024-10-01$1049.68/sh−9$9,447→ 17,615 total - Sale
Common Stock
2024-10-01$1050.60/sh−6$6,304→ 17,609 total - Sale
Common Stock
2024-10-01$1056.68/sh−3$3,170→ 17,586 total - Sale
Common Stock
2024-10-01$1042.31/sh−1$1,042→ 17,678 total - Sale
Common Stock
2024-10-01$1044.62/sh−9$9,402→ 17,664 total - Sale
Common Stock
2024-10-01$1052.44/sh−4$4,210→ 17,596 total - Sale
Common Stock
2024-10-01$1054.90/sh−3$3,165→ 17,589 total - Sale
Common Stock
2024-10-01$1057.38/sh−2$2,115→ 17,584 total - Sale
Common Stock
2024-10-01$1046.53/sh−9$9,419→ 17,648 total - Sale
Common Stock
2024-10-01$1051.51/sh−9$9,464→ 17,600 total - Sale
Common Stock
2024-10-01$1059.28/sh−2$2,119→ 17,582 total
Footnotes (16)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
- [F10]Represents volume-weighted average price of sales of 6 shares of Company stock on October 1, 2024 at prices ranging from $1,050.27 to $1,050.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F11]Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2024 at prices ranging from $1,051.10 to $1,051.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F12]Represents volume-weighted average price of sales of 4 shares of Company stock on October 1, 2024 at prices ranging from $1,052.37 to $1,052.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F13]Represents volume-weighted average price of sales of 4 shares of Company stock on October 1, 2024 at prices ranging from $1,053.06 to $1,053.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F14]Represents volume-weighted average price of sales of 3 shares of Company stock on October 1, 2024 at prices ranging from $1,054.76 to $1,054.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F15]Represents volume-weighted average price of sales of 3 shares of Company stock on October 1, 2024 at prices ranging from $1,056.55 to $1,056.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F16]Represents volume-weighted average price of sales of 2 shares of Company stock on October 1, 2024 at prices ranging from $1,057.28 to $1,057.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 3 shares of Company stock on October 1, 2024 at prices ranging from $1,041.10 to $1,041.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 5 shares of Company stock on October 1, 2024 at prices ranging from $1,043.12 to $1,043.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2024 at prices ranging from $1,044.14 to $1,044.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 7 shares of Company stock on October 1, 2024 at prices ranging from $1,045.00 to $1,045.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2024 at prices ranging from $1,046.14 to $1,046.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 12 shares of Company stock on October 1, 2024 at prices ranging from $1,047.09 to $1,047.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 12 shares of Company stock on October 1, 2024 at prices ranging from $1,048.00 to $1,048.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2024 at prices ranging from $1,049.18 to $1,049.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001187443
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:02 PM ET
- Size
- 34.1 KB